Decheng Capital

Vickers Venture leads $4.3m funding in UK-based biopharma firm SiSaf

By
Posted

The company says it plans to use the investment to accelerate the development of its dermatology pipeline.

High valuations in Asia often reflective of growth opportunities: Abrar Mir, Quadria

Explaining the largely untapped opportunity for PE in Asia, Mir said that most industries in the region are highly under-funded, capital markets are still nascent, and debt financing continues to be an expensive and highly risky alternative.


SG’s co-working startup JustCo eyes acquisitions for regional expansion

Co-working space operator JustCo plans to set up 100 centers by 2020 in Asia and is looking to acquire firms that complement its operations.


Singapore: Sembcorp to buy UK Power Reserve from Inflexion, Equistone for $287m

Sembcorp will acquire 42.5% each from Inflexion and Equistone, and 15% from UKPR management.


Singapore entrepreneur Eric Cheng buys Japan’s FX, crypto currency exchange for $50m

Cheng, the CEO of Upper Joyful Ltd, will own controlling stake in the two firms – FX Trade and its affiliate BitTrade Co Ltd.


Singapore Exchange to delay start of new India futures after lawsuit

SGX had been due to launch the SGX India Futures on June 4.


Singapore finds its fintech ambitions hampered by immigration curbs

The city-state’s goal of becoming a high-tech financial hub are running into real-world problems of labour supply and demand.


Grab launches GrabFood in Singapore, targets rest of Southeast Asia next

GrabFood will be available in six Southeast Asian countries within this quarter, including Indonesia, Thailand, Vietnam, Malaysia, Singapore and the Philippines.


Malaysia scraps multibillion-dollar high-speed rail project to Singapore

The decision would deal a setback to construction and rail companies in Asia, including those from China and Japan, that are keen to gain a slice of orders.


Singapore: Clinical stage biotech Lion TCR bags $20m from Yashang Capital, others

The funds will be used to advance on-going clinical trials for therapy against a form of liver cancer